HomePharmaceutical
Pharmaceutical
The high cost rare diseases: R54m for one-off injection
The Sunday Times reports on one SA family's journey with their daughter, who has spinal muscular atrophy, trying to access hugely expensive new breakthrough...
SA pharmacies 'knowingly stock dangerous and ineffective products'
The US Food and Drug Administration's Tainted Products Marketed as Dietary Supplements database lists hundreds of products with hidden active ingredients that are unsafe...
Running out of antibiotics under development — WHO report
A World Health Organisation (WHO) report shows a serious lack of antibiotics under development to combat the growing threat of antimicrobial resistance. Most of...
Health activists embrace IP policy draft, IPSA says it fuels misconceptions
Health activists have welcomed the SA Department of Trade and Industry’s latest draft intellectual property policy saying it contains important reforms that will make life-saving...
Amgen's cholesterol drug cuts cardiovascular risk – trial
Amgen said its cholesterol fighter Repatha significantly reduced the risk of heart attacks, strokes and death in patients with heart disease, according to initial...
Increases in drug prices puts pressure on European healthcare
Increases in cancer medicine prices in the UK, despite many medicines going off-patent, suggest that in many cases NHS price negotiations are failing to...
OECD: Many new drugs are bad value for money
An Organisation of Economic Co-operation and Development report has criticised the pricing strategy of the pharmaceutical industry, claiming that many new drugs are simply bad value for...
SA medicine price increase off to an early start
Aspen Pharmacare has welcomed both the 7.5% increase in the single exit price for medicines and scheduled substances announced by Health Minister Aaron Motsoaledi...
Treatment hope for ALCL patients
Stunning ‘before’ and ‘after’ scans of cancer patient Ian Brooks released by the Christie Hospital in Manchester, looked almost too good to be true,...